Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Med Vet Entomol ; 34(4): 402-410, 2020 12.
Article in English | MEDLINE | ID: mdl-32426867

ABSTRACT

Toscana virus (TOSV) is a prominent arthropod-borne viral agent of human central nervous system infections occurring in the Mediterranean region. The main transmission route to susceptible individuals involves sandflies as vectors. Despite several reports revealing widespread TOSV activity in Turkey, vectors remained unidentified. A sandfly field survey was carried out in five provinces in Central, Southeast and Mediterranean Anatolia in 2017 to identify TOSV and related sandfly-borne phleboviruses and Leishmania parasites, with evidence for circulation in the region. A total of 7136 sandfly specimens, collected via standard methods, were evaluated in 163 pools. TOSV was detected in 11 pools (6.7%), comprising Phlebotomus major sensu lato, Sergentomyia dentata and Phlebotomus papatasi species. TOSV partial L and S segment sequences were characterized, that phylogenetically clustered with local and global genotype A strains. An amino acid substitution outside the conserved motifs of the viral polymerase, also present in previous TOSV sequences in endemic regions, was observed. Leishmania tropica was detected in a single pool of Ph. sergentii (0.6%). This is the first report of TOSV in sandflies from Turkey, and this study further provides evidence for additional sandfly species with the potential to transmit TOSV.


Subject(s)
Phlebotomus , Sandfly fever Naples virus , Animals , Bunyaviridae Infections/transmission , Humans , Insect Vectors/parasitology , Insect Vectors/virology , Leishmania tropica/isolation & purification , Leishmaniasis, Cutaneous/transmission , Phlebotomus/classification , Phlebotomus/parasitology , Phlebotomus/virology , Phylogeny , Psychodidae/classification , Psychodidae/parasitology , Psychodidae/virology , RNA, Viral , Sandfly fever Naples virus/genetics , Sandfly fever Naples virus/isolation & purification , Turkey/epidemiology , Vector Borne Diseases/parasitology , Vector Borne Diseases/transmission , Vector Borne Diseases/virology
2.
Med Vet Entomol ; 34(4): 394-401, 2020 12.
Article in English | MEDLINE | ID: mdl-32438501

ABSTRACT

In the past decade, leishmaniasis seems to be re-emerging in Balkan countries. There are serious implications that Kosovo is a visceral leishmaniasis endemic region with autochthonous transmission; nevertheless, surveillance of vectors, reservoirs or the disease is not yet established. Gaining knowledge about sandfly vector species is a prerequisite for the development of a monitoring and control plan in the future. After a long gap in research of over 70 years, sandfly studies in Kosovo were resumed in 2014. During this presence/absence study, nine sandfly species were detected: Phlebotomus papatasi, Ph. perfiliewi, Ph. tobbi, Ph. neglectus, Ph. simici, Ph. balcanicus, Ph. alexandri, Ph. mascittii and Sergentomyia minuta. Three species are new with regard to the fauna of Kosovo - Ph. alexandri, Ph. balcanicus and Ph. mascittii. Besides increased diversity, changes in the number of collected specimens and distribution range of species were recorded, with Ph. neglectus being the most dominant species with the widest distribution. Testing of randomly chosen females for Leishmania spp. DNA resulted the in detection of L. tropica in a specimen of Ph. neglectus. The presence of numerous vector species in the sandfly fauna of Kosovo pose a threat for the re-emergence of vector-borne diseases. Therefore, continuous surveillance is recommended with regular updates on vector distribution and abundance.


Subject(s)
Leishmania/isolation & purification , Phlebotomus/classification , Animals , DNA, Protozoan , Insect Control , Insect Vectors/classification , Insect Vectors/parasitology , Kosovo/epidemiology , Leishmania/genetics , Leishmaniasis/transmission , Phlebotomus/parasitology , Psychodidae , Vector Borne Diseases/transmission
3.
Niger J Clin Pract ; 22(4): 478-484, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30975950

ABSTRACT

BACKGROUND: Analgesic protocol is needed following gynecologic surgery to ensure early mobilization, decrease the duration in the post-anesthetic care unit and hospitalization, and provide patient comfort. Transversus abdominis plane (TAP) blocks are used in the treatment of acute postoperative pain after lower abdominal surgery. TAP block may be a better choice of postoperative pain control. In the present study, the efficacy of ultrasound-guided TAP block on pain control and postoperative opioid consumption was evaluated in patients undergoing a total abdominal hysterectomy. METHODS: Fifty patients undergoing total abdominal hysterectomy were included in this study. Patients were divided into TAP block (n = 25) and control groups (n = 25). Both groups postoperative patient-controlled analgesia (PCA) was planned during 24 h postoperatively. Patients were assessed 1, 2, 4, 6, 12, 18, and 24 h postoperatively using the Visual Analog Scale (VAS), Ramsey Sedation Score, PCA demand, morphine consumption, first analgesic requirement time, and adverse reactions. RESULTS: When compared with the control group, the time to first analgesic requirement in the TAP block group was significantly lower (P < 0.05). The amount of additional analgesia also differed significantly (P < 0.001). In the TAP group, the VAS was significantly lower at 2, 4, 6, 12, 18, and 24 h postoperatively compared to the control group (P < 0.05). There was no statistically significant difference in adverse reactions. CONCLUSION: TAP block can effectively treat postoperative pain as part of multimodal analgesia in patients undergoing total abdominal hysterectomy.


Subject(s)
Abdominal Muscles/innervation , Analgesia/methods , Analgesics, Opioid/administration & dosage , Hysterectomy , Morphine/administration & dosage , Nerve Block/methods , Pain, Postoperative/prevention & control , Adult , Female , Humans , Middle Aged , Pain Management , Prospective Studies , Single-Blind Method , Time Factors , Treatment Outcome , Visual Analog Scale
4.
Asian Pac J Cancer Prev ; 16(18): 8155-61, 2015.
Article in English | MEDLINE | ID: mdl-26745054

ABSTRACT

The prognostic significance of AgNOR proteins in stage II-III rectal cancers treated with chemoradiotherapy was evaluated. Silver staining was applied to the 3µm sections of parafin blocked tissues from 30 rectal cancer patients who received 5-FU based chemoradiotherapy from May 2003 to June 2006. The microscopic displays of the cells were transferred into the computer via a video camera. AgNOR area (nucleolus organizer region area) and nucleus area values were determined as a nucleolus organizer regions area/total nucleus area (NORa/ TNa). The mean NORa/TNa value was found to be 9.02±3.68. The overall survival and disease free survival in the high NORa/TNa (>9.02) patients were 52.2 months and 39.4 months respectively, as compared to 100.7 months and 98.4 months in the low NORa/TNa (<9.02) cases. (p<0.001 and p<0.001 respectively). In addition, the prognosis in the high NORa/TNa patients was worse than low NORa/TNa patients (p<0.05). In terms of overall survival and disease-free survival, a statistically significant negative correlation was found with the value of NORa/TNa in the correlations tests. Cox regression analyses demostrated that overall survival and disease-free survival were associated with lymph node status (negative or positive) and the NORa/TNa value. We suggest that two-dimensional AgNOR evaluation may be a safe and usable parameter for prognosis and an indicator of cell proliferation instead of AgNOR dots.


Subject(s)
Adenocarcinoma/pathology , Cell Nucleus/pathology , Nucleolus Organizer Region/pathology , Stomach Neoplasms/pathology , Adenocarcinoma/therapy , Adenocarcinoma/ultrastructure , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cell Nucleus/ultrastructure , Chemoradiotherapy , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Staging , Nucleolus Organizer Region/ultrastructure , Prognosis , Silver Staining , Stomach Neoplasms/therapy , Stomach Neoplasms/ultrastructure , Survival Rate
5.
Am J Clin Oncol ; 38(1): 68-73, 2015 Feb.
Article in English | MEDLINE | ID: mdl-23563207

ABSTRACT

OBJECTIVES: To assess the outcomes of overall survival and posttransplantation survival in patients with Hodgkin lymphoma (HL) undergoing autologous stem cell transplantation (ASCT) because of the development of relapse or resistance after chemotherapy (CT) or CT plus radiotherapy (combined modality treatment, CMT). METHODS: Forty-five patients undergoing ASCT because of the development of relapse or resistance after CT or CMT for HL were enrolled in the study. Radiotherapy was given as involved-field radiotherapy. Patients were treated with CT alone (n=25) or CMT (n=20). These 2 groups were further divided into 2 subgroups: the patients with early-stage (I to II) and advanced-stage (III to IV) HL. RESULTS: Median patients age was 29 years (range, 16 to 60 y) and the median follow-up was 60 months (range, 12 to 172 mo). In the patients with advanced-stage HL, there was no statistically significant difference in overall survival between irradiated and nonirradiated patients (n=18, irradiated n=4 and nonirradiated n=14). However, in the patients with early-stage disease, there was a significant difference in 5- and 10-year overall survival between the irradiated and nonirradiated groups (81% vs. 48% and 66% vs. 24%, respectively, P=0.045; n=26, irradiated n=16 and nonirradiated n=10). In the univariate analysis, irradiated group and involvement of 1 to 2 nodal regions were found to be significant for overall survival, whereas irradiated group, early stage, and involvement of 1 to 2 nodal regions were found to be significant for posttransplantation survival. However, only irradiated group was found to be significant for posttransplantation survival in multivariate analysis (P<0.05). CONCLUSIONS: Addition of involved-field radiotherapy to CT in patients undergoing ASCT after relapse or recurrence failed to provide survival benefit in patients with advanced HL, while a survival benefit was observed in patients with early-stage HL. Radiotherapy should be considered as part of CMT in the patients with early-stage HL, which should not be neglected.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemoradiotherapy/methods , Hodgkin Disease/therapy , Mediastinal Neoplasms/therapy , Neoplasm Recurrence, Local/therapy , Stem Cell Transplantation/methods , Adolescent , Adult , Bleomycin/therapeutic use , Carboplatin/therapeutic use , Carmustine/therapeutic use , Cisplatin/therapeutic use , Cohort Studies , Cytarabine/therapeutic use , Dacarbazine/therapeutic use , Dexamethasone/therapeutic use , Doxorubicin/therapeutic use , Etoposide/therapeutic use , Female , Hodgkin Disease/pathology , Humans , Ifosfamide/therapeutic use , Male , Mediastinal Neoplasms/pathology , Melphalan/therapeutic use , Methylprednisolone/therapeutic use , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Retrospective Studies , Transplantation, Autologous , Treatment Outcome , Vinblastine/therapeutic use , Young Adult
6.
Leuk Lymphoma ; 54(11): 2474-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23442062

ABSTRACT

Conditioning regimens used during stem cell transplant provide prolonged control or cure of the disease in patients with acute lymphoblastic leukemia (ALL). In this study, we present a comparison of treatment results for 95 patients with ALL who underwent allogeneic hematopoietic stem cell transplant (AHSCT) with total body irradiation plus cyclophosphamide (TBI + Cy) or busulfan plus cyclophosphamide (Bu + Cy) as conditioning regimen. Median age was 25 (range: 9-54) years. Median follow-up was 24 (range: 3-107) months. Median overall survival (OS) was found to be 29 months. Median event-free survival (EFS) was 9 months. Median OS was 37 months in the TBI + Cy arm, while it was 12 months in the Bu + Cy arm, suggesting a significant advantage favoring the TBI + Cy arm (p = 0.003). Median EFS was 13 months in the TBI + Cy arm, while it was 4 months in the Bu + Cy arm, indicating a significant difference (p = 0.006). In univariate and multivariate analysis, it was found that high OS and EFS were significantly correlated with TBI + Cy conditioning regimen and lack of transplant-related mortality (p < 0.05). The TBI + Cy conditioning regimen was found to be superior to the Bu + Cy regimen in patients with ALL undergoing AHSCT regarding both OS and EFS.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Hematopoietic Stem Cell Transplantation , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Transplantation Conditioning , Whole-Body Irradiation , Adolescent , Adult , Busulfan/administration & dosage , Child , Cyclophosphamide/administration & dosage , Female , Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Male , Middle Aged , Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality , Prognosis , Recurrence , Tissue Donors , Transplantation, Homologous , Treatment Outcome , Young Adult
7.
Neurosurg Rev ; 27(1): 65-9, 2004 Jan.
Article in English | MEDLINE | ID: mdl-12955582

ABSTRACT

Gamma radiation is known to cause serious damage in the brain, and many agents have been used for neuroprotection. In this study, lipid peroxidation levels and histopathological changes in brain tissues of whole-body irradiated rats with likely radiation injury were compared to those with melatonin and vitamin E protection. Forty rats in four equal groups were used. The control group received neither radiation nor medication. The remaining groups received doses of 720 cGy in two equal fractions 12 h apart. The second group received radiation but no medication, the third received radiation plus 100 mg/kg per day of vitamin E i.p., and the fourth received radiation plus 100 mg/kg per day of melatonin i.p. over 5 days. On the 10th postoperative day, all the rats were decapitated and specimens from parietal cortices were analyzed for tissue malondialdehyde (MDA) levels and histopathological changes. Increases in MDA were relatively well prevented by melatonin treatment but less so with vitamin E therapy. On histopathological examination, melatonin significantly reduced the rates of edema, necrosis, and neuronal degeneration, whereas vitamin E reduced only necrosis. Neither substance was capable of preventing vasodilatation. In conclusion, melatonin may be useful in preventing the pathological changes of secondary brain damage as a result of free oxygen radicals generated by irradiation.


Subject(s)
Antioxidants/therapeutic use , Brain Damage, Chronic/prevention & control , Gamma Rays/adverse effects , Melatonin/therapeutic use , Neuroprotective Agents/therapeutic use , Vitamin E/therapeutic use , Animals , Brain/drug effects , Brain/pathology , Brain/radiation effects , Brain Damage, Chronic/etiology , Brain Damage, Chronic/pathology , Disease Models, Animal , Female , Male , Rats , Rats, Wistar , Whole-Body Irradiation/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...